Systems and methods for treating eye diseases
AssigneeJ.D. Franco & Co., LLC
InventorsMichael Calhoun, Jeff Franco, Robert M. Vidlund
Life of this patent
Estimating the term…
Abstract
A method may include accessing a terminal branch of an ophthalmic artery through a face of a subject. Additionally, the method may include positioning a device within the ophthalmic artery of the subject and treating at least one of a blockage, a stenosis, a lesion, plaque or other physiology in at least one of the ophthalmic artery or a junction between an internal carotid artery and the ophthalmic artery.
Claims21
1-23. (canceled)
A method for treating glaucoma or age-related macular degeneration (AMD), comprising:
- accessing an ophthalmic artery (OA) through an access vasculature site of a subject via a first device;
- positioning the first device or a second device within the OA;
- and
- removing material from the OA, to thereby treat glaucoma or AMD, wherein the material includes one or more of a blockage, a stenosis, a lesion, plaque, or other physiology in the OA.
A method for treating glaucoma or age-related macular degeneration (AMD), comprising:
- accessing an ophthalmic artery (OA) through an access vasculature site of a subject via a first device;
- positioning the first device or a second device within the OA of the subject, wherein the positioned first device or second device includes an atherectomy device and at least one embolic protection element;
- removing material from the OA via the atherectomy device, to thereby treat glaucoma or AMD, wherein the material includes at least one of a blockage, a stenosis, a lesion, plaque, or other physiology in the OA;
- and
- during the removing, inhibiting passage of the removed material via the at least one embolic protection element.
A method for treating glaucoma or age-related macular degeneration (AMD), comprising:
- accessing an ophthalmic artery (OA) through an access vasculature site of a subject via a first device;
- positioning a first embolic protection element within an internal carotid artery (ICA) of the subject via the first device;
- positioning a second device within the OA of the subject, the second device including an atherectomy device and a second embolic protection element located distal of the atherectomy device;
- deploying the atherectomy device and the second embolic protection element in the OA;
- removing material from the OA via the atherectomy device, to thereby treat glaucoma or AMD;
- and
- during the removing, inhibiting passage of the removed material downstream into the ICA and the OA via the first embolic protection element and the second embolic protection element, respectively.
Dependencies are inferred from the claim text.